🇺🇸 FDA
Pipeline program

human HER2-targeted CAR-M cells

ITT-20231107-0257-02

Phase 1 mab active

Quick answer

human HER2-targeted CAR-M cells for Gastric Cancer is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Gastric Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials